• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Pharmacological properties of procaterol, a newly synthetized, specific beta 2-adrenoceptor stimulant. Part I. Effects on the CNS (author's transl)].

作者信息

Hashimoto K, Shintani S, Yamashita S, Tei S, Takai M, Tsutsui M, Kawamura K, Ohkawa T, Hiyama T, Yabuuchi Y

出版信息

Nihon Yakurigaku Zasshi. 1979 Apr 20;75(3):271-89.

PMID:43821
Abstract

Effects of procaterol (PRO) on the CNS were investigated in comparison with those of salbutamol (SAL) and isoproterenol (ISO). PRO, 15 to 50 mg/kg given subcutaneously suppressed spontaneous movement in mice, rats and rabbits and with a large dose, 1000 mg/kg, the animals became quiet and immobile. In dogs, PRO produced similar symptoms and in addition, there was nausea and vomiting. The animals recovered within 3--8 hours. ID50's in depressing spontaneous movement were 20.2 and 245 mg/kg for PRO, 51.1 and 133 mg/kg for SAL and 2.37 and 143 mg/kg for ISO, respectively, both by the subcutaneous and oral routes of administration. Methamphetamine induced increase in motility and fighting behavior was also suppressed by PRO when similar doses were given. PRO had no effect on coordinating movement, halothane anesthesia, drug and electric stimulation induced convulsions and body temperature, and there was no muscle relaxant action. However, PRO in large doses prolonged sleeping time with hexobarbital. The analgesic effect of PRO was not observed with Haffner's and Landall Selitto's methods but acetic acid induced writhing was suppressed by PRO. PRO had little effect on spontaneous EEGs either cortical or from deep structures, and EEG arousal responses. The effects of PRO on the CNS were slight and nonspecific, and similar to those of SAL and ISO.

摘要

相似文献

1
[Pharmacological properties of procaterol, a newly synthetized, specific beta 2-adrenoceptor stimulant. Part I. Effects on the CNS (author's transl)].
Nihon Yakurigaku Zasshi. 1979 Apr 20;75(3):271-89.
2
Pharmacological studies of mabuterol, a new selective beta 2-stimulant. III: Effects on the central nervous system, striated muscle and carbohydrate and lipid metabolism.
Arzneimittelforschung. 1984;34(11A):1652-8.
3
[Pharmacological properties of procaterol, a newly synthesized, specific beta 2-adrenoceptor stimulant. Part II. Effects on the peripheral organs (author's transl)].
Nihon Yakurigaku Zasshi. 1979 May;75(4):333-64.
4
[Effects of suloctidil on the central and peripheral nervous systems].[舒洛地尔对中枢和外周神经系统的作用]
Nihon Yakurigaku Zasshi. 1983 Sep;82(3):191-212.
5
General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.新型抗血栓药物西洛他唑的一般药理学特性。第一部分:对中枢神经系统的作用。
Arzneimittelforschung. 1985;35(7A):1157-62.
6
[General pharmacology of 6-amino-2-fluoromethyl-3-(o-tolyl)-4(3H)-quinazolinone (afloqualone), a new centrally acting muscle relaxant. I. Effects on the central nervous system (author's transl)].新型中枢性肌肉松弛剂6-氨基-2-氟甲基-3-(邻甲苯基)-4(3H)-喹唑啉酮(阿夫唑仑)的一般药理学。I. 对中枢神经系统的作用(作者译)
Nihon Yakurigaku Zasshi. 1981 Oct;78(4):347-57.
7
General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.新型β-肾上腺素能受体拮抗剂卡维地洛的一般药理学特性
Arzneimittelforschung. 1990 Jul;40(7):735-46.
8
[Profile of pharmacological actions of NAB 365 (clenbuterol), a novel broncholytic agent with selective activity on adrenergic beta2-receptors (author's transl)].新型支气管溶解剂NAB 365(克仑特罗)对肾上腺素能β2受体具有选择性活性的药理作用概况(作者译)
Arzneimittelforschung. 1976;26(7a):1404-20.
9
General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system.盐酸N-(2,6-二甲基苯基)-8-吡咯烷乙酰胺半水合物的一般药理学研究。首次通讯:对中枢神经系统的作用。
Arzneimittelforschung. 1988 Oct;38(10):1398-409.
10
General pharmacology of recombinant human tumor necrosis factor. 2nd communication: effects on central nervous system functions.
Arzneimittelforschung. 1990 Feb;40(2 Pt 1):225-31.

引用本文的文献

1
Clinical pharmacokinetics and relative bioavailability of oral procaterol.口服丙卡特罗的临床药代动力学及相对生物利用度
Pharm Res. 1993 Apr;10(4):603-5. doi: 10.1023/a:1018966506819.